The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better

Published:2024-06 Issue: Volume:18 Page:100649
ISSN:2666-6677
Container-title:American Journal of Preventive Cardiology
language:en
Short-container-title:American Journal of Preventive Cardiology

Author:

Mhaimeed Omar,Burney Zain A,Schott Stacey L^ORCID,Kohli Payal^ORCID,Marvel Francoise A,Martin Seth S^ORCID

Publisher

Elsevier BV

Reference102 articles.

1. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis;Ference;J Am Coll Cardiol,2012

2. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur Heart J,2017

3. A century of cholesterol and coronaries: from plaques to genes to statins;Goldstein;Cell,2015

4. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis;Skalen;Nature,2002

5. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications;Tabas;Circulation,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing the cardiovascular risk-reducing effects of polyunsaturated fatty acids in fish oil and krill oil: A network meta-analysis;Journal of Functional Foods;2024-09

2. Ezetimibe use and mortality after myocardial infarction: A nationwide cohort study;American Journal of Preventive Cardiology;2024-09

3. Effectiveness of PCSK9 inhibitors: A Target Trial Emulation framework based on Real-World Electronic Health Records;PLOS ONE;2024-08-22

4. Therapeutic potentials of peptide-derived nanoformulations in atherosclerosis: present status and future directions;International Journal of Smart and Nano Materials;2024-07-02

5. No Standard Risk Factors Is the Marker for Clinical Outcomes in Patients With Myocardial Infarction;JACC: Asia;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3